Recombinant IL6 (Sirukumab Biosimilar) antibody

Catalog No. ABIN7487981

The Mammalian Cells Monoclonal anti-IL6 (Sirukumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect IL6 (Sirukumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL6 (Sirukumab Biosimilar) antibody (ABIN7487981)

Target: IL6 (Sirukumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL6 (Sirukumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL6 (Sirukumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Sirukumab Biosimilar - Anti-IL6 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL6 (Sirukumab Biosimilar)

Target: IL6 (Sirukumab Biosimilar)

Target Type: Biosimilar

Background: CNTO 136
Sirukumab is a human monoclonal antibody designed for the treatment of rheumatoid arthritis. It acts against the proinflammatory cytokine Interleukin 6 (IL-6).

CAS-No: 1194585-53-9